Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ritter Pharmac. Com (RTTR)

Ritter Pharmac. Com (RTTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,677
  • Shares Outstanding, K 46,153
  • Annual Sales, $ 0 K
  • Annual Income, $ -10,130 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta -0.43
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.33
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.64
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/12/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2850 +57.19%
on 04/23/20
0.7900 -43.29%
on 05/18/20
+0.1540 (+52.38%)
since 04/22/20
3-Month
0.1700 +163.53%
on 03/16/20
0.8600 -47.91%
on 03/02/20
+0.2151 (+92.36%)
since 02/21/20
52-Week
0.1500 +198.67%
on 12/26/19
1.2700 -64.72%
on 07/02/19
-0.3820 (-46.02%)
since 05/22/19

Business Summary

Ritter Pharmaceuticals, Inc. is involved in developing therapeutic products to treat inflammatory, gastrointestinal and metabolic diseases. Its lead product candidate is RP-G28, a novel microbiome modulator, which is under development for the reduction of symptoms associated with lactose intolerance....

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.5758
1st Resistance Point 0.5119
Last Price 0.4480
1st Support Level 0.4121
2nd Support Level 0.3762
3rd Support Level N/A

See More

52-Week High 1.2700
Fibonacci 61.8% 0.8422
Fibonacci 50% 0.7100
Fibonacci 38.2% 0.5778
Last Price 0.4480
52-Week Low 0.1500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar